Rooted in proven principles. Focused on what lasts.
aevX Bio was founded on a simple idea: people living with hair loss deserve better than treatments that are inconvenient, inconsistent, or difficult to stay on. Hair loss will affect around half of us over the course of our lives, yet treatment options remain far from where they should be and do not address women.
Built by people who'd use it. Backed by people who'd prescribe it.
aevX Bio started with a simple frustration: the only drugs that reliably work for hair loss come with side effects nobody should have to accept. Co-founders Julien Grogg, a drug-delivery scientist, and Glen George, a healthcare operator from Switzerland's clinical network, set out to fix that with a better way to deliver skillfully combined, synergistic androgen modulating agents locally to the scalp. Behind them is a medical advisory board of practising endocrinologists, dermatologists and aesthetics surgeons who've already said they'd offer AV^2 to their own patients.
Built on Complementary Expertise
aevX combines entrepreneurial execution and drug-development expertise with a strong medical, regulatory, corporate and intellectual property network.
Start a Conversation